Clinical Trial

Can the Phoenix Sign be Elicited With D5W

Name: Can the Phoenix Sign be Elicited With D5W — clinical trial record (NCT07568470)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.

Trial Details

NCT Number	NCT07568470
Lead Sponsor	US Neuropathy Centers
Conditions	Drop Foot
Enrollment	600 participants
Start Date	2026-04-10
Primary Completion	2026-09-01 (estimated)
Study Completion	2027-01-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-05